Wendy F Dicicco's Net Worth

$588 Million

Estimate Recalculated Sep 18, 2024 03:41PM EST

Who is Wendy F Dicicco?

Wendy F Dicicco has an estimated net worth of $588 Million. This is based on reported shares across multiple companies, which include CANNAPHARMARX, INC., SWK Holdings Corp, II-VI INC, EyePoint Pharmaceuticals, Inc., Renovacor, Inc., KENSEY NASH CORP, and Akari Therapeutics Plc.

SEC CIK

Wendy F Dicicco's CIK is 0001225165

Past Insider Trading and Trends

2022 was Wendy F Dicicco's most active year for acquiring shares with 13 total transactions. Wendy F Dicicco's most active month to acquire stocks was the month of July. 2008 was Wendy F Dicicco's most active year for disposing of shares, totalling 29 transactions. Wendy F Dicicco's most active month to dispose stocks was the month of May. 2008 saw Wendy F Dicicco paying a total of $592,012.70 for 48,000 shares, this is the most they've acquired in one year. In 2008 Wendy F Dicicco cashed out on 62,050 shares for a total of $1,069,991.62, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CANNAPHARMARX, INC. (CPMD) Snapshot price: $0.012631

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 27
Form 3
—
0
—
—
0
No matching records found

SWK Holdings Corp (SWKH) Snapshot price: $17.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+44.34%
1.9K
$17.64
$33,498.36
6.18K
Dec 30
Form 4
+85.25%
1.97K
$17.00
$33,507.00
4.28K
Sep 30
Form 4
+96.77%
1.14K
$17.47
$19,863.39
2.31K
Jun 30
Form 4
∞
1.18K
$16.88
$19,834.00
1.18K
Mar 31
Form 3
—
0
—
—
0
No matching records found

II-VI INC (COHR) Snapshot price: $68.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$24.31
-$44,432.50
30.55K
Scheduled
Apr 28
Form 4
—
0
$26.16
-$61,035.00
30.55K
Jan 31
Form 4
-12.59%
-4.40K
$29.36
-$129,169.92
30.55K
Scheduled
Dec 23
Form 4
—
0
$19.14
-$25,279.60
34.95K
Sep 8
Form 4
+11.83%
3.7K
$21.67
$80,092.32
34.95K
Aug 20
Form 4
—
0
$18.57
-$10,354.00
31.25K
Mar 30
Form 4
+16.76%
4.49K
$17.84
$80,012.40
31.25K
Aug 15
Form 4
+27.18%
5.72K
—
—
26.77K
Aug 16
Form 4
+24.45%
4.13K
—
—
21.05K
Aug 17
Form 4
+34.21%
4.31K
—
—
16.91K
Aug 18
Form 4
+58.49%
4.65K
—
—
12.6K
Aug 20
Form 4
+8.90%
325
$28.20
$9,165.00
3.98K
Jan 25
Form 4
+117.91%
1.98K
—
—
3.65K
Aug 21
Form 4
+148.15%
1K
$23.60
$23,600.00
1.68K
Aug 17
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Feb 7
Form 4
+237.50%
475
$17.64
$8,379.95
675
Dec 9
Form 4
—
0
—
—
0
Feb 9
Form 4
+100.00%
100
$34.40
$3,440.00
200
Oct 30
Form 4
∞
100
$30.06
$3,006.00
100
Apr 27
Form 4
—
0
—
—
0
Feb 10
Form 3
—
0
—
—
0
No matching records found

EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $7.97

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 5
Form 4
—
0
—
—
0
Jun 20
Form 4
+68.18%
3K
—
—
7.4K
Feb 9
Form 4
+131.58%
2.5K
—
—
4.4K
Feb 9
Form 4
—
0
—
—
0
Jun 22
Form 4
∞
1.9K
—
—
1.9K
Feb 28
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Jul 15
Form 3
—
0
—
—
0
No matching records found

Renovacor, Inc. No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-18.80K
—
—
0
Dec 1
Form 4
—
0
—
—
0
Jun 17
Form 3
—
0
—
—
0
Form 4
+434.28%
18.8K
—
—
23.13K
Jan 24
Form 4
—
0
—
—
0
Sep 3
Form 3
—
0
—
—
0
No matching records found